ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19
Stock Information for BioSig Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.